Insulin potentiation therapy (IPT) is an alternative medicine pharmacologic strategy for the chemotherapy of cancer using insulin and low-dose chemotherapy. Whilst formal studies were recognized as being required back in 1986, no conventionally recognized study has been published in the subsequent 20 years.
| Property | Value |
|---|
| dbpprop:abstract
|
- Insulin potentiation therapy (IPT) is an alternative medicine pharmacologic strategy for the chemotherapy of cancer using insulin and low-dose chemotherapy. Whilst formal studies were recognized as being required back in 1986, no conventionally recognized study has been published in the subsequent 20 years. The therapeutic approach is said to take advantage of the endogenous molecular biology of cancer cells, specifically insulin and insulin like growth factor secretion, and the interaction of these biochemicals with their specific receptors. By using insulin in conjunction with chemotherapy drugs, significantly less drug (about 10-15 % of a standard dose) can be targeted more specifically and more effectively to cancer cell populations, thus virtually eliminating dose-related side effects while claiming enhancing antineoplastic effects.
|
| dbpprop:date
| |
| dbpprop:hasPhotoCollection
| |
| dbpprop:reference
| |
| dbpprop:wikiPageUsesTemplate
| |
| rdf:type
| |
| rdfs:comment
|
- Insulin potentiation therapy (IPT) is an alternative medicine pharmacologic strategy for the chemotherapy of cancer using insulin and low-dose chemotherapy. Whilst formal studies were recognized as being required back in 1986, no conventionally recognized study has been published in the subsequent 20 years.
|
| rdfs:label
|
- Insulin potentiation therapy
|
| owl:sameAs
| |
| skos:subject
| |
| foaf:page
| |
| is dbpprop:redirect
of | |
| is owl:sameAs
of | |
![[RDF Data]](/statics/sw-cube.png)
